Godel, M.; Ortone, G.; Anobile, D.P.; Pasino, M.; Randazzo, G.; Riganti, C.; Kopecka, J.
Targeting Mitochondrial Oncometabolites: A New Approach to Overcome Drug Resistance in Cancer. Pharmaceutics 2021, 13, 762.
https://doi.org/10.3390/pharmaceutics13050762
AMA Style
Godel M, Ortone G, Anobile DP, Pasino M, Randazzo G, Riganti C, Kopecka J.
Targeting Mitochondrial Oncometabolites: A New Approach to Overcome Drug Resistance in Cancer. Pharmaceutics. 2021; 13(5):762.
https://doi.org/10.3390/pharmaceutics13050762
Chicago/Turabian Style
Godel, Martina, Giacomo Ortone, Dario Pasquale Anobile, Martina Pasino, Giulio Randazzo, Chiara Riganti, and Joanna Kopecka.
2021. "Targeting Mitochondrial Oncometabolites: A New Approach to Overcome Drug Resistance in Cancer" Pharmaceutics 13, no. 5: 762.
https://doi.org/10.3390/pharmaceutics13050762
APA Style
Godel, M., Ortone, G., Anobile, D. P., Pasino, M., Randazzo, G., Riganti, C., & Kopecka, J.
(2021). Targeting Mitochondrial Oncometabolites: A New Approach to Overcome Drug Resistance in Cancer. Pharmaceutics, 13(5), 762.
https://doi.org/10.3390/pharmaceutics13050762